| Dr Ashwin Subramani Krishna, MD | |
|
800 Rose St, Department Of Pediatrics, Lexington, KY 40536 | |
| (859) 323-1305 | |
| Not Available |
| Full Name | Dr Ashwin Subramani Krishna |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 800 Rose St, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073720314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | TP357 (Kentucky) | Secondary |
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | 46475 (Kentucky) | Primary |
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented at the annual American Association of Blood Banks (AABB) meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtained through apheresis.
Working with an asthma coach helps to significantly reduce hospitalizations of low-income, African-American children with asthma, results of a new, two-year study show.
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat technologies, has received clearance from the U.S. Food and Drug Administration to expand the indication for the Acclarent AERA® Eustachian Tube Balloon Dilation System to include its use in patients as young as 18. The device was previously cleared only for adults aged 22 and older.
Tissue Regeneration Materials Unit (Guoping Chen, Unit Director) at the International Center for Materials Nanoarchitectonics (MANA) (Masakazu Aono, Director General, MANA), NIMS (Sukekatsu Ushioda, President) successfully developed gold nanoparticles that have functional surfaces and act on osteogenic differentiation of stem cells.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashwin Subramani Krishna, MD 800 Rose St, Department Of Pediatrics, Lexington, KY 40536 Ph: (859) 323-1305 | Dr Ashwin Subramani Krishna, MD 800 Rose St, Department Of Pediatrics, Lexington, KY 40536 Ph: (859) 323-1305 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented at the annual American Association of Blood Banks (AABB) meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtained through apheresis.
Working with an asthma coach helps to significantly reduce hospitalizations of low-income, African-American children with asthma, results of a new, two-year study show.
Johnson & Johnson Medical Devices Companies today announced that Acclarent, Inc., a leader in developing minimally-invasive Ear, Nose & Throat technologies, has received clearance from the U.S. Food and Drug Administration to expand the indication for the Acclarent AERA® Eustachian Tube Balloon Dilation System to include its use in patients as young as 18. The device was previously cleared only for adults aged 22 and older.
Tissue Regeneration Materials Unit (Guoping Chen, Unit Director) at the International Center for Materials Nanoarchitectonics (MANA) (Masakazu Aono, Director General, MANA), NIMS (Sukekatsu Ushioda, President) successfully developed gold nanoparticles that have functional surfaces and act on osteogenic differentiation of stem cells.
› Verified 2 days ago
Preeti Ramachandran, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St Fl Ha4, Lexington, KY 40536 Phone: 859-323-6754 Fax: 859-323-6754 | |
Robin L Feese, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1780 Nicholasville Rd, Ste 301, Lexington, KY 40503 Phone: 859-277-6636 Fax: 859-277-1455 | |
Dr. Mina Hazem Halim Hanna, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 800 Rose St # Ms 471, Lexington, KY 40536 Phone: 248-854-3120 Fax: 859-323-8031 | |
Jacob A Bishop, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 245 Fountain Ct, Lexington, KY 40509 Phone: 859-323-6861 | |
Donna Glandon Grigsby, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5481 | |
Dr. John Charles Vance, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1760 Nicholasville Rd, Suite 406, Lexington, KY 40503 Phone: 859-276-1221 Fax: 859-278-0047 | |
Dr. Kimberly Renee Dennis Northrip, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 740 S Limestone, J426, Lexington, KY 40536 Phone: 859-323-6426 |